Researchers in Japan found that although the Alzheimer’s drug lecanemab successfully removes amyloid plaques from the brain, it does not restore the brain’s waste-clearing system within the first few months of treatment. The study suggests that by the time symptoms appear, damage to nerve cells and the glymphatic system is already well established, making short-term […]
Source link